
Keywords: کاربیدوپا; PD; Parkinson's disease; l-dopa; 3-4 dihydroxy-l-phenylalanine; PBLs; peripheral blood lymphocytes; ROS; reactive oxygen species; 8-oxodG; 8-oxo-7,8-dihydro-2â²-deoxyguanosine; MN; micronuclei; TBARS; thiobarbituric acid-reactive substances; PrCAR; prote